Phase
Condition
Depression
Treatment
N/AClinical Study ID
Ages 18-40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Non-depressed adults aged 18-40 years;
OR adults aged 18-40 years with clinically diagnosed major depressive disorderaccording to DSM-V criteria not currently receiving antidepressant treatment;
OR adults aged 18-40 years with clinically diagnosed major depressive disorder withat least 2 weeks of treatment with a selective serotonin reuptake inhibitor;
OR aged 18-40 years adults with clinically diagnosed major depressive disorder withat least 2 weeks of treatment with a serotonin norepinephrine reuptake inhibitor;
All participants will be asymptomatic and no signs/symptoms of disease according tothe American College of Sports Medicine 10th edition Guidelines for Exercise Testingand Prescription (chest pain or pressure, dizziness, joint pain, and signs ofcardiovascular disease);
Systolic blood pressure 140 mmHg and diastolic pressure 90 mmHg at screening;
Non-diabetic
Not taking any other medications that might affect the physiological variables ofinterest (beta blockers, tricyclic antidepressants, antipyretics, diuretics, etc.);;
Between the 20th and 80th percentiles for sex- and age-appropriate VO2max accordingto the American College of Sports Medicine 10th edition Guidelines for ExerciseTesting and Prescription;
English proficiency;
Capable of providing informed consent.
Exclusion
Exclusion Criteria:
BMI > 35
Are pregnant or planning to become pregnant in the next 12 months;
Concurrently participate in another study involving physical activity or weightloss;
Plan to have surgery or relocate outside the area within the next year;
Medications that could alter cardiovascular or thermoregulatory responses toexercise (beta blockers, antipyretics, tricyclic antidepressants, diuretics, etc.);
Allergy to latex or adhesive;
Tobacco use;
Illegal/recreational drug use;
Exertional chest pain or musculoskeletal pain;
Contraindications to a maximal exercise test or an indication for early terminationof the exercise test according to the American College of Sports Medicine 10thedition Guidelines for Exercise Testing and Prescription;
Abnormal resting or exercise electrocardiogram (ECG);
Any bleeding disorders, gastric ulcers, allergies to NSAIDS, asthma, kidney/liverdisorders, and taking any other anticoagulants;
History of Crohn's disease, diverticulitis, or similar gastrointestinal disease;
Co-morbid psychiatric disorders (psychosis, schizophrenia, bipolar disorder, panicdisorder, obsessive compulsive disorder, etc.);
Active suicidal ideation (moderate or high suicidality);
Use of psychoactive or psychopharmacological drugs other than SSRI and SNRIs withinone year of participating.
Study Design
Study Description
Connect with a study center
Noll Laboratory
University Park, Pennsylvania 16802
United StatesSite Not Available
Noll Laboratory
University Park 5216774, Pennsylvania 6254927 16802
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.